Breztri Aerosphere is a combination inhaler containing three medications: budesonide, glycopyrrolate, and formoterol fumarate. It is used to manage COPD and is administered by inhalation. Patients should consult their healthcare provider for personalized instructions on how to use Breztri Aerosphere.
How is Breztri Aerosphere administered?
Breztri Aerosphere is an orally inhaled medication. It is important to follow the specific instructions provided by a healthcare professional for proper use.
What are the components of Breztri Aerosphere?
Breztri Aerosphere is a triple-therapy inhaler containing:
* Budesonide, an inhaled corticosteroid [1].
* Glycopyrrolate, an anticholinergic [1].
* Formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA) [1].
What conditions does Breztri Aerosphere treat?
Breztri Aerosphere is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD) [1].
What is the typical dosage of Breztri Aerosphere?
The recommended dose of Breztri Aerosphere is two inhalations once daily [1].
What are the potential side effects of Breztri Aerosphere?
Common side effects reported in clinical trials include nasopharyngitis, oral candidiasis, bronchitis, and upper respiratory tract infection [1]. It is crucial for patients to discuss any potential side effects with their doctor.
How does Breztri Aerosphere work?
Budesonide works by reducing inflammation in the airways. Glycopyrrolate relaxes the muscles around the airways, making it easier to breathe. Formoterol fumarate is a bronchodilator that helps open the airways [1].
How long does it take for Breztri Aerosphere to work?
Patients may experience symptom improvement within the first week of treatment, but their full benefit may not be seen for several weeks or months [1].
Are there alternatives to Breztri Aerosphere for COPD management?
Yes, there are other treatment options for COPD, including other inhaled corticosteroid/long-acting muscarinic antagonist/LABA combinations, as well as monotherapies and dual-combination inhalers. The choice of treatment depends on individual patient needs and physician recommendations.
What is the patent status of Breztri Aerosphere?
Information on the specific patent status and expiry dates for Breztri Aerosphere can be found through resources like DrugPatentWatch.com [2].
Who manufactures Breztri Aerosphere?
Breztri Aerosphere is manufactured by AstraZeneca [1].
What patient education is needed for using Breztri Aerosphere?
Patients need to be instructed on how to prime and use the inhaler correctly, including proper technique for inhaling the medication. They should also be advised on cleaning the mouthpiece regularly and understanding the risks and benefits of the medication.
How should Breztri Aerosphere be stored?
Breztri Aerosphere should be stored at room temperature. It is important to protect it from freezing and excessive heat [1].
*
**Sources
[1] https://www.breztri.com/
[2] https://drugpatentwatch.com/